Table 1.
Risk in prethreshold eye |
||||||
---|---|---|---|---|---|---|
Icrop category |
Low risk | High risk | ||||
Zone | Stage | Plus disease | At least one eye prethreshold no. of patients | No. of patients | No. | % |
I | 3 | Yes | 29 | 0 | 29 | 100 |
I | 3 | No | 23 | 1 | 22 | 95.7 |
I | 1 or 2 | Yes | 19 | 0 | 19 | 100 |
I | 1 or 2 | No | 117 | 9 | 108 | 92.3 |
II | 3 | Yes | 271 | 13 | 258 | 95.2 |
II | 3 | No | 303 | 295 | 8 | 2.6 |
II | 2 | Yes | 66 | 11 | 55 | 83.3 |
Total | 828 | 329 | 499 | 60.3 |
ICROP, International Classification of Retinopathy of Prematurity.20
Risk of poor structural outcome was based on the RM-ROP2 risk model analysis for each eye (a risk analysis program based on natural history data from the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Study).7 Low risk was less than 0.15; high risk was 0.15 or greater. Plus disease was defined as a degree of dilation and tortuosity of the posterior retinal blood vessels meeting or exceeding that of a standard photograph.2